Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5075400
Max Phase: Preclinical
Molecular Formula: C50H62ClN9O7S2
Molecular Weight: 1000.69
Molecule Type: Unknown
Associated Items:
ID: ALA5075400
Max Phase: Preclinical
Molecular Formula: C50H62ClN9O7S2
Molecular Weight: 1000.69
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCCCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1
Standard InChI: InChI=1S/C50H62ClN9O7S2/c1-29-31(3)69-49-42(29)43(34-15-17-36(51)18-16-34)55-38(46-58-57-32(4)60(46)49)24-40(62)52-19-22-66-20-9-8-10-21-67-27-41(63)56-45(50(5,6)7)48(65)59-26-37(61)23-39(59)47(64)53-25-33-11-13-35(14-12-33)44-30(2)54-28-68-44/h11-18,28,37-39,45,61H,8-10,19-27H2,1-7H3,(H,52,62)(H,53,64)(H,56,63)/t37-,38+,39+,45-/m1/s1
Standard InChI Key: PWFGHENEZLVBOP-DPSJZEHMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1000.69 | Molecular Weight (Monoisotopic): 999.3902 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Klein VG, Bond AG, Craigon C, Lokey RS, Ciulli A.. (2021) Amide-to-Ester Substitution as a Strategy for Optimizing PROTAC Permeability and Cellular Activity., 64 (24.0): [PMID:34881891] [10.1021/acs.jmedchem.1c01496] |
Source(1):